top of page


Accuracy of package inserts of SARS-CoV-2 rapid antigen tests: a secondary analysis of manufacturer versus systematic review data.

Bigio J, MacLean EL, Das R, Sulis G, Kohli M, Berhane S, Dinnes J, Deeks JJ, Brümmer LE, Denkinger CM, Pai M.

Lancet Microbe. 2023 Oct 13:S2666-5247(23)00222-7. doi: 10.1016/S2666-5247(23)00222-7.

How can we tackle the overuse of antibiotics in low- and middle-income countries?

Sulis G, Sayood S, Gandra S.

Expert Rev Anti Infect Ther. 2023 Sep 25:1-13. doi: 10.1080/14787210.2023.2263643. 

Pharmacy engagement in TB prevention and care: not if, but how?

Miller R, Wafula F, Eman KU, Rakesh PS, Faleye BO, Duggan C, Sousa Pinto G, Heitkamp P, Rana N, Klinton JS, Sulis G, Oga-Omenka C, Pai M. 

BMJ Glob Health. 2023 Jul;8(7):e013104. doi: 10.1136/bmjgh-2023-013104. 

Use of standardised patients to assess tuberculosis case management by private pharmacies in Patna, India: A repeat cross-sectional study

Svadzian A, Daniels B, Sulis G, Das J, Daftary A, Kwan A, Das V, Das R, Pai M. 

PLOS Glob Public Health. 2023 May 26;3(5):e0001898. doi: 10.1371/journal.pgph.0001898. 

Engaging pharmacists and medicine vendors in antimicrobial stewardship in LMICs

Oga-Omenka C, Okafor U, Sulis G.

Lancet Infect Dis. 2023 May 19. doi: 10.1016/S1473-3099(23)00342-0. 

Sex-disaggregated effectiveness data reporting in COVID-19 vaccine research: a systematic review

Sulis G, Kim JY, Rodrigue V, Gore G, Peebles A, Ulrich AK, Horn M, Basta NE.

Commun Med. 2023 May 19. doi: 10.1038/s43856-023-00297-7. 

Lassa fever vaccine candidates: A scoping review of vaccine clinical trials

Sulis G, Peebles A, Basta NE.

Trop Med Int Health. 2023 Apr 24. doi: 10.1111/tmi.13876.

Integrating tuberculosis and COVID-19 molecular testing in Lima, Peru: a cross-sectional, diagnostic accuracy study

MacLean EL, Villa-Castillo L, Espinoza-Lopez P, Caceres T, Sulis G, Kohli M, Pai M, Ugarte-Gil C.

Lancet Microbe. 2023 Apr 14:S2666-5247(23)00042-3. doi: 10.1016/S2666-5247(23)00042-3.

Do private providers initiate anti-tuberculosis therapy on the basis of chest radiographs? A standardised patient study in urban India

Svadzian A, Daniels B, Sulis G, Das J, Daftary A, Kwan A, Das V, Das R, Pai M.

Lancet Reg Health Southeast Asia. 2023 Feb 1. doi: 10.1016/j.lansea.2023.100152.

A scoping review on the risk of tuberculosis in specific population groups: can we expand the World Health Organization recommendations?

Bigio J, Viscardi A, Gore G, Matteelli A, Sulis G.

Eur Respir Rev 2023; 32: 220127. doi: 10.1183/16000617.0127-2022.


Antibody tests for identification of current and past infection with SARS-CoV-2

Fox T, Geppert J, Dinnes J, Scandrett K, Bigio J, Sulis G, Hettiarachchi D, Mathangasinghe Y, Weeratunga P, Wickramasinghe D, Bergman H, Buckley BS, Probyn K, Sguassero Y, Davenport C, Cunningham J, Dittrich S, Emperador D, Hooft L, Leeflang MM, McInnes MD, Spijker R, Struyf T, Van den Bruel A, Verbakel JY, Takwoingi Y, Taylor-Phillips S, Deeks JJ.

Cochrane Database Syst Rev. 2022 Nov 17;11:CD013652. doi: 10.1002/14651858.CD013652.pub2.

Pneumococcal vaccination uptake and missed opportunities for vaccination among Canadian adults: A cross-sectional analysis of the Canadian Longitudinal Study on Aging (CLSA)

Sulis G, Rodrigue V, Wolfson C, McMillan JM, Kirkland SA, Andrew MK, Basta NE.

PLoS One. 2022 Oct 14;17(10):e0275923. doi: 10.1371/journal.pone.0275923. 

Influenza vaccine coverage and factors associated with non-vaccination among adults at high risk for severe outcomes: An analysis of the Canadian Longitudinal Study on Aging

Gravagna K, Wolfson C, Sulis G, Buchan SA, McNeil S, Andrew MK, McMillan J, Kirkland S, Basta NE.

PLoS One. 2022 Sep 30;17(9):e0275135. doi: 10.1371/journal.pone.0275135.

Comment on: Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19)

Sulis G, Pai M, Gandra S.

J Antimicrob Chemother. 2022 May 31:dkac180. doi: 10.1093/jac/dkac180.

A comparison of national vaccination policies to prevent serogroup B meningococcal disease.

Sulis G, Horn M, Borrow R, Basta NE.

Vaccine. 2022 Jun 9; 40(26): 3647-3654. Epub 2022 May 14. doi: 10.1016/j.vaccine.2022.04.101.

India’s ban on antimicrobial fixed dose combinations: winning the battle, losing the war?.

Sulis G, Pradhan R, Kotwani A, Gandra S. J Pharm Policy Pract. 2022 Apr 28;15(1):33. doi: 10.1186/s40545-022-00428-w.

Exposure to WHO AWaRe antibiotics and isolation of multi-drug resistant bacteria: a systematic review and meta-analysis

Sulis G, Sayood S, Katukoori S, Bollam N, George I, Yaeger L, Chavez MA, Tetteh E, Yerrabelli S, Pulcini C, Harbarth S, Figueras A, Mertz D, Sharland M, Moja L, Huttner B, Gandra S. Clin Microbiol Infect. Epub 2022 Mar 23. doi: 10.1016/j.cmi.2022.03.014.

Do private providers give patients what they demand, even if it is inappropriate? A randomized study utilizing unannounced standardized patients in Kenya

Kwan A, Boone C, Sulis G, Gertler P. BMJ Open. 2022 Mar 18;12(3):e058746. doi: 10.1136/bmjopen-2021-058746.

Factors Associated with Willingness to Receive a COVID-19 Vaccine among 23,819 Adults Aged 50 years and Older: An Analysis of the Canadian Longitudinal Study on Aging

Basta N, Sohel N, Sulis G, Wolfson C, Maimon G, Griffith L, Kirkland S, McMillian J, Thompson M, Raina P.

Am J Epidemiol. 2022 Feb 15; kwac029. doi: 10.1093/aje/kwac029.

Comparative effectiveness of regimens for drug-susceptible tuberculous meningitis in children and adolescents: a systematic review and aggregate-level data meta-analysis

Sulis G, Tavaziva G, Gore G, Benedetti A, Solomons R, van Toorn R, Thee S, Day J, Verkuijl S, Brands A, Viney K, Masini T, Ahmad Khan F, Chiang SS.

Open Forum Infect Dis. Open Forum Infect Dis. 2022 Jun; 9(6):ofac108. doi: 10.1093/ofid/ofac108.

Prescribing practices for presumptive TB among private general practitioners in South Africa: a cross-sectional standardized patient study

Salomon A, Boffa J, Moyo S, Chikovore J, Sulis G, Mkhombo T, Daniels B, Kwan A, Wu S, Pai M, Daftary A.

BMJ Glob Health. 2022 Jan; 7(1). doi: 10.1136/bmjgh-2021-007456.


Influenza vaccination uptake among Canadian adults before and during the COVID-19 pandemic: An analysis of the Canadian Longitudinal Study on Aging (CLSA)

Sulis G*, Basta NE*, Wolfson C, Kirkland S, McMillan J, Griffith LE, Raina P.

Vaccine 2022 Jan 24; 40(3):503-511. Epub 2021 Dec 4. doi: 10.1016/j.vaccine.2021.11.088.

Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: an interrupted time series analysis

Sulis G, Batomen B, Kotwani A, Pai M, Gandra S.

PLoS Med 2021; 18(7):e1003682. doi: 10.1371/journal.pmed.1003682.

Antimicrobial resistance in low- and middle-income countries: current status and future directions.

Sulis G, Sayood S, Gandra S.

Expert Rev Anti Infect Ther. 2022 Feb; 20(2): 147-160. Epub 2021 Jul 19. doi: 10.1080/14787210.2021.1951705.

Access to antibiotics: not a problem in some low and middle-income countries

Sulis G, Gandra S.

Lancet Glob Health. 2021 May; 9(5): e561-e562. Epub 2021 Mar 10. doi: 10.1016/S2214-109X(21)00085-1. 


Differential yield of universal versus selective drug-susceptibility testing of tuberculosis patients in high burden countries: a systematic review and meta-analysis

Svadzian A*, Sulis G*, Gore G, Pai M, Denkinger C.M.

BMJ Glob Health 2020 Oct; 5(10):e003438. doi: 10.1136/bmjgh-2020-003438.


Antibiotic overuse in the primary health care setting: a secondary data analysis of standardized patient studies from India, China and Kenya

Sulis G, Daniels B, Kwan A, Gandra S, Daftary A, Das J*, Pai M*.

BMJ Glob Health. 2020 Sep; 5(9):e003393. doi: 10.1136/bmjgh-2020-003393.

Active testing of groups at increased risk of acquiring SARS-CoV-2 in Canada: costs and human resource needs

Campbell J, Uppal A, Oxlade O, Fregonese F, Bastos M, Lan Z, Law S, Russell WA, Sulis G, Winters N, Yanes Lane M, Brisson M, Laszlo S, Evans T, Menzies D.

Can Med Assoc J. 2020 Oct 5;192(40):E1146-E1155. Epub 2020 Sep 9. doi: 10.1503/cmaj.201128. French version: 10.1503/cmaj.201128-f.

Pharmacokinetic study of two different rifabutin doses co-administered with lopinavir/ritonavir in African HIV and tuberculosis co-infected adult patients

Kouanda S, Ouedraogo HG, Cisse K, Compaoré TR, Sulis G, Diagbouga S, Roggi A, Tarnagda G, Villani P, Sangare L, Simporé J, Regazzi M, Matteelli A.

BMC Infect Dis. 2020 Jun 26; 20(1): 449. doi: 10.1186/s12879-020-05169-2.

Antibiotic prescription practices in primary care in low- and middle-income countries: a systematic review and meta-analysis

Sulis G, Adam P, Nafade V, Gore G, Daniels B, Daftary A, Das J, Gandra S*, Pai M*.

PLoS Med. 2020 Jun 16; 17(6): e1003139. doi: 10.1371/journal.pmed.1003139.

COVID-19 and tuberculosis in South Africa: a dangerous combination

Boffa J, Mhlaba T, Sulis G, Moyo S, Sifumba Z, Pai M, Daftary A. S Afr Med J. 2020 Mar 27; 110 (5): 341-342. doi: 10.7196/SAMJ.2020.v110i5.14747.

Pharmacokinetics of plasma lopinavir and ritonavir in tuberculosis-HIV co-infected African adult patients also receiving rifabutin 150 or 300 mg three times per week

Ouedraogo HG, Matteelli A, Sulis G, Compaore RT, Diagbouga S, Tiendrebeogo S, Roggi A, Cisse K, Giorgetti PF, Villani P, Sangare L, Simpore J, Regazzi M, Kouanda S.

Ann Clin Microbiol Antimicrob. 2020 Jan 22; 19(1):3. doi: 10.1186/s12941-020-0345-6.

Isoniazid-resistant tuberculosis: a problem we can no longer ignore

Sulis G, Pai M.

PLoS Med. 2020 Jan 21; 17(1): e1003023. doi: 10.1371/journal.pmed.1003023.


Over-the-counter antibiotic dispensing by pharmacies: a standardised patient study in Udupi district, India

Nafade V, Huddart S, Sulis G, Daftary A, Miraj SS, Saravu K, Pai M.

BMJ Glob Health. 2019 Nov 1; 4(6); e001869. doi: 10.1136/bmjgh-2019-001869.

Diagnostic accuracy of stool Xpert MTB/Rif for detection of pulmonary tuberculosis in children: a systematic review and meta-analysis

MacLean E, Sulis G, Denkinger CM, Johnston JC, Pai M, Ahmad-Khan F.

J Clin Microbiol. 2019 May 24; 57(6). pii: e02057-18. doi: 10.1128/JCM.02057-18.


Tuberculosis in pregnancy: a treacherous yet neglected issue

Sulis G, Pai M.

J Obstet Gynaecol Can. 2018 Aug; 40(8):1003-1005. doi: 10.1016/j.jogc.2018.04.041. French version: 10.1016/j.jogc.2018.06.007.

Implementation of tuberculosis prevention for exposed children, Burkina Faso

Sulis G, Combary A, Getahun H, Gnanou S, Giorgetti PF, Konseimbo A, Capone S, Hamada Y, Baddeley A, Matteelli A.

Bull World Health Organ. 2018 Jun 1; 96(6): 386-392. Epub 2018 Apr 20. doi: 10.2471/BLT.17.201343.

Xpert MTB/RIF as add-on test to microscopy in a low tuberculosis incidence setting

Sulis G, Agliati A, Pinsi G, Bozzola G, Foccoli P, Gulletta M, Caligaris S, Tomasoni L, El Hamad I, Matteelli A.

Eur Respir J. 2018 Mar 22; 51(3). doi: 10.1183/13993003.02345-2017.

Policies and practices on the programmatic management of LTBI: a survey in the African Region

Sulis G, Carvalho ACC, Capone S, Hamada Y, Giorgetti PF, da Silva Martins P, Getahun H, Matteelli A. Int J Tuberc Lung Dis. 2018 Feb 1;22(2): 158-164. doi: 10.5588/ijtld.17.0563.

Delamanid: a broken dream for patients with MDR-TB?

Sulis G.

BMJ Opinion. 2018 Jan 26. 


Addressing the global health funding gap: Italy needs to step up!

Sulis G.

BMJ Global Health Blog. 2017 Oct 13. 

Cross-border collaboration for improved TB care and prevention: policies, tools and experiences

Dara M, Sulis G, Centis R, D’Ambrosio L, de Vries G, Douglas P, Garcia D, Jansen N, Zuroweste E, Migliori GB.

Int J Tuberc Lung Dis. 2017 Jul 1; 21(7): 727-736. doi: 10.5588/ijtld.16.0940.

Missing tuberculosis patients in the private sector: business as usual will not deliver results

Sulis G, Pai M.

Public Health Action. 2017 Jun 21;7(2):80-81. doi: 10.5588/pha.17.0039.

Antiretroviral therapy in HIV infected children with tuberculosis: a systematic review

Sulis G, Amadasi S, Odone A, Penazzato M, Matteelli A.

Pediatr Infect Dis J. 2018 May;37(5):e117-e125. Epub 2017 Sep 7. doi: 10.1097/INF.0000000000001784.

Migration and infectious diseases

Castelli F, Sulis G.

Clin Microbiol Infect. 2017 Mar 20. Pii S1198-743X(17)30178-7. doi: 10.1016/j.cmi.2017.03.012.

Tuberculosis elimination and the challenge of latent tuberculosis

Matteelli A, Sulis G, Capone S, D’Ambrosio L, Migliori GB, Getahun H.

Presse Med. 2017 Mar; 46(2 Pt 2):e13-e21. Epub 2017 Mar 6. doi: 10.1016/j.lpm.2017.01.015.

The cursed duet today: Tuberculosis and HIV co-infection

Tiberi S*, Carvalho AC*, Sulis G*, Vaghela D*, Rendon A, Mello FC, Rahman A, Matin N, Zumla A, Pontali E.

Presse Med. 2017 Mar; 46(2 Pt 2):e23-e39. Epub 2017 Feb 27. doi: 10.1016/j.lpm.2017.01.017.

Tuberculosis – A World Health Organization perspective

Sotgiu G, Sulis G, Matteelli A.

Microbiol Spectrum. 2017 Jan; 5(1): TNM17-0036-2016. doi: 10.1128/microbiolspec.TNMI7-0036-2016.


Recent developments on the diagnosis and management of tuberculosis

Sulis G, Centis R, Sotgiu G, D’Ambrosio L, Pontali E, Spanevello A, Matteelli A, Zumla A, Migliori GB.

NPJ Prim Care Respir Med. 2016 Nov 3;26: 16078. doi: 10.1038/npjpcrm.2016.78.

European policies in the management of tuberculosis among migrants

D'Ambrosio L, Centis R, Dara M, Solovic I, Sulis G, Zumla A, Migliori GB.

Int J Infect Dis. 2017 Mar; 56:85-89. Epub Nov 9. doi: 10.1016/j.ijid.2016.11.002

Crossborder travel and multidrug resistant tuberculosis (MDRTB) in Europe

Matteelli A, Centis R, Sulis G, Tadolini M.

Travel Med Infect Dis. 2016 Nov-Dec; 14(6):588-590. doi: 10.1016/j.tmaid.2016.11.017.

Active tuberculosis case finding among pregnant women: a pilot project in Burkina Faso

Sulis G, Gnanou S, Roggi A, Konseimbo A, Giorgetti PF, Castelli F, Matteelli A.

Int J Tuberc Lung Dis, 2016 Oct;20(10):1306-1308. doi: 10.5588/ijtld.16.0132.

Faster for less, the new "Shorter" regimen for multidrug-resistant tuberculosis

Sotgiu G, Tiberi S, D'Ambrosio L, Centis R, Alffenaar JW, Caminero JA, Arbex M, Alarcon Guizado V, Aleksa A, Dore S, Gaga M, Gualano G, Kunst H, Payen MC, Roby Arias JA, Skrahina A, Solovic I, Sulis G, Tadolini M, Zumla A, Migliori GB.

Eur Respir J. 2016 Sep 1. pii: ERJ-01249-2016. doi: 10.1183/13993003.01249-2016.

Surgery and pleuro-pulmonary tuberculosis: a scientific literature review.

Subotic D, Yablonskiy P, Sulis G, Cordos I, Petrov D, Centis R, D’Ambrosio L, Sotgiu G, Migliori GB.

J Thorac Dis, 2016 Jul; 8(7):E474-85. doi: 10.21037/jtd.2016.05.59.

Tuberculosis 2015: burden, challenges and strategy for control and elimination

Raviglione MC, Sulis G.

Infect Dis Rep. 2016 Jun 24;8(2):6570. doi: 10.4081/idr.2016.6570.

Effectiveness and Safety of Imipenem-Clavulanate Added to an Optimized Background Regimen (OBR) Versus OBR Control Regimens in the Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis

Tiberi S, Sotgiu G, D'Ambrosio L, Centis R, Arbex MA, Alarcon Arrascue E, Alffenaar JW, Caminero JA, Gaga M, Gualano G, Skrahina A, Solovic I, Sulis G, Tadolini M, Alarcon Guizado V, De Lorenzo S, Roby Arias AJ, Scardigli A, Akkerman OW, Aleksa A, Artsukevich J, Avchinko V, Bonini EH, Chong Marín FA, Collahuazo López L, de Vries G, Dore S, Kunst H, Matteelli A, Moschos C, Palmieri F, Papavasileiou A, Payen MC, Piana A, Spanevello A, Vargas Vasquez D, Viggiani P, White V, Zumla A, Migliori GB.

Clin Infect Dis. 2016 May 1;62(9):1188-90. doi: 10.1093/cid/ciw088.

Comparison of effectiveness and safety of imipenem/clavulanate- versus meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB

Tiberi S, Sotgiu G, D'Ambrosio L, Centis R, Abdo Arbex M, Alarcon Arrascue E, Alffenaar JW, Caminero JA, Gaga M, Gualano G, Skrahina A, Solovic I, Sulis G, Tadolini M, Alarcon Guizado V, De Lorenzo S, Roby Arias AJ, Scardigli A, Akkerman OW, Aleksa A, Artsukevich J, Auchynka V, Bonini EH, Chong Marín FA, Collahuazo López L, de Vries G, Dore S, Kunst H, Matteelli A, Moschos C, Palmieri F, Papavasileiou A, Payen MC, Piana A, Spanevello A, Vargas Vasquez D, Viggiani P, White V, Zumla A, Migliori GB.

Eur Respir J. 2016 Apr 13. pii: ERJ-00214-2016. doi: 10.1183/13993003.00214-2016.

Effectiveness and safety of meropenem/clavulanate-containing regimens in the treatment of MDR- and XDR-TB

Tiberi S, Payen MC, Sotgiu G, D'Ambrosio L, Alarcon Guizado V, Alffenaar JW, Abdo Arbex M, Caminero JA, Centis R, De Lorenzo S, Gaga M, Gualano G, Roby Arias AJ, Scardigli A, Skrahina A, Solovic I, Sulis G, Tadolini M, Akkerman OW, Alarcon Arrascue E, Aleska A, Avchinko V, Bonini EH, Chong Marín FA, Collahuazo López L, de Vries G, Dore S, Kunst H, Matteelli A, Moschos C, Palmieri F, Papavasileiou A, Spanevello A, Vargas Vasquez D, Viggiani P, White V, Zumla A, Migliori GB.

Eur Respir J. 2016 Apr;47(4):1235-43. doi: 10.1183/13993003.02146-2015.

Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeaeinfection in adolescents in Northern Italy: an observational school-based study

Matteelli A, Capelli M, Sulis G, Toninelli G, Carvalho AC, Pecorelli S, Caruso A, Bonfanti C, Gargiulo F, Donato F; (on behalf of the Clamigon Study Group).

BMC Public Health. 2016 Feb 29;16(1):200. doi: 10.1186/s12889-016-2839-x.

Prior to 2016

Chlamydia trachomatis genotypes in school adolescents, Italy

Stefanelli P, Sulis G, Renna G, Gargiulo F, Zanotti P, Capelli M, De Francesco MA, Donato F, Pecorelli S, Matteelli A.

Infection. 2015 Dec; 43(6):739-41. Epub 2015 May 5. doi: 10.1007/s15010-015-0787-5.

A case of Rickettsia felis infection imported from Nepal

Sulis G, Rodari P, Caligaris S, Tomasoni LR, Castelli F, Gulletta M.

J Travel Med. 2015 Jul-Aug; 22(4):276-8. Epub 2015 Apr 17. doi: 10.1111/jtm.12207.

Management of Latent Infection to End the TB Epidemic

Sulis G, Urbinati L, Matteelli A.

PEAH (Policies for Equitable Access to Health). 2015 Jul 20. 

Towards tuberculosis elimination: an action framework for low-incidence countries

Lönnroth K, Migliori GB, Abubakar I, D’Ambrosio L, de Vries G, Diel R, Douglas P, Falzon D, Gaudreau M.A, Goletti D, González Ochoa E, LoBue P, Matteelli A, Njoo H, Solovic I, Story A, Talal Tayeb T, van den Werf M.J, Weil D, Zellweger JP, Abdel Aziz M, Al Lawati MRM, Aliberti S, Arrazola de Onate W, Barreira D, Bhatia V, Blasi F, Bloom A, Bruchfeld J, Castelli F, Centis R, Chemtob D, Cirillo DM, Colorado A, Dadu A, Dahle U, De Paoli L, Dias HM, Duarte R, Fattorini L, Gaga M, Getahun H, Glaziou P, Goguadze L, del Granado M, Järvinen A, Kwon G-Y, Mosca D, Nahid P, Nishikiori N, Noguer I, O’Donnell J, Pace-Asciak A, Pompa MG, Popescu G, Robalo Cordeiro C, Rønning K, Ruhwald M, Sculier JP, Simunović A, Smith-Palmer A, Sotgiu G, Sulis G, Umeki K, Uplekar M, van Weezenbeek C, Vasankari T, Vitillo RJ, Voniatis C, Wanlin M, Raviglione MC.

Eur Respir J. 2015 Apr; 45(4):928-52. doi: 10.1183/09031936.00214014.

The impact of Xpert MTB/RIF® depends on service coordination: experience in Burkina Faso

Moyenga I, Roggi A, Sulis G, Diande S, Tamboura D, Tagliani E, Castelli F, Matteelli A.

Int J Tuberc Lung Dis. 2015 Mar; 19(3):285-7. doi: 10.5588/ijtld.14.0629.

Tuberculosis: epidemiology and control

Sulis G, Roggi A, Matteelli A, Raviglione MR.

Mediterr J Hematol Infect Dis. 2014 Nov 1; 6(1):e2014070. doi: 10.4084/MJHID.2014.070,

Whipple’s Disease concomitant with Candida esophagitis and subsequent Giardia lamblia co-infection

Sulis G, Villanacci V, Missale G, Salemme M, Castelli F, Caligaris S.

Eur J Gastroenterol Hepatol. 2014 Oct; 26(10):1181-5. doi: 10.1097/MEG.0000000000000154.

Clinical and epidemiological features of HIV/AIDS infection among migrants at first access to healthcare services as compared to Italian patients in Italy: a retrospective multicentre study, 2000-2010

Sulis G, El Hamad I, Fabiani M, Rusconi S, Maggiolo F, Guaraldi G, Bozzi G, Bernardini C, Lichtner M, Stentarelli C, Carenzi L, Francisci D, Saracino A, Castelli F; The HIV/Migrants Study Group.

Infection. 2014 Oct; 42(5):859-67. doi: 10.1007/s15010-014-0648-7.

Chlamydia trachomatis conjunctivitis in a male teenager: a case report

Sulis G, Urbinati L, Franzoni A, Gargiulo F, Carvalho ACC, Matteelli A.

Infez Med. 2014 Jun 1; 22(2):140-3. 

The relationship between anaemia and malaria: apparently simple, yet controversial

Castelli F, Sulis G, Caligaris S.

Trans R Soc Trop Med Hyg. 2014 Apr. doi: 10.1093/trstmh/tru012.

Clinical and Immunological outcomes according to adherence to first-line HAART in a urban and rural cohort of HIV-infected patients in Burkina Faso, West Africa: a longitudinal Cohort study

Focà E, Odolini S, Sulis G, Calza S, Pietra V, Rodari P, Giorgetti P, Noris A, Ouedraogo P, Simpore J, Pignatelli S, Castelli F.

BMC Infect Dis. 2014 Mar; 14:153. doi: 10.1186/1471-2334-14-153.

Poor-quality anti-tuberculosis drugs threaten the global disease control strategy

Sulis G, Matteelli A.

PEAH (Policies for Equitable Access to Health). 2013 Dec 5.

International migrations and HIV care in the rural District of Nanoro, Burkina Faso

Autino B, Odolini S, Nitiema H, Kiema D, Melzani A, Pietra V, Martinetto M, Bettinzoli M, Simpore J, Sulis G, Focà E, Castelli F.

Bull Soc Pathol Exot 105, 130 (2012). doi: 10.1007/s13149-012-0229-x.


[Globalization and educational needs in the field of international health cooperation. The TropEd Master program in International Health and the Italian Master in Tropical Medicine and Global Health].

De Nardi S, De Maio G, Bisoffi Z, Franzetti M, Cattaneo A, Caligaris S, Sulis G, Bartoloni A, Castelli F.

Giorn Ital Med Trop, 2012; 17(1-4): 24-32.


bottom of page